Usefulness of CA 19–9 for pancreatic cancer screening in patients with new-onset diabetes - ScienceDirect
CA19–9 decrease and survival according to platelet level in patients with advanced pancreatic cancer | BMC Cancer | Full Text
Carbohydrate antigen 19-9 elevation without evidence of malignant or pancreatobiliary diseases | Scientific Reports
CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial - The Lancet Oncology
Carbohydrate antigen 19-9 — tumor marker: Past, present, and future
The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal - Ballehaninna - Journal of Gastrointestinal Oncology
![PDF] Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f7bb4eb6de25f6ecb9323cbef8061896f020a0da/2-Table1-1.png "PDF] Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy? | Semantic Scholar")
PDF] Assessing Prognosis in Metastatic Pancreatic Cancer by the Serum Tumor Marker CA 19-9: Pretreatment Levels or Kinetics during Chemotherapy? | Semantic Scholar
Causative conditions of elevated CA 19-9 levels in the elevated CA 19-9... | Download Scientific Diagram
Premium Photo | Blood sample with abnormal ca 19 9 report or tumor marker test for pancreatic cancer
The clinical utility of normal range carbohydrate antigen 19-9 level as a surrogate marker in evaluating response to treatment in pancreatic cancer-a report of two cases. | Semantic Scholar
Evaluating the efficacy of tumor markers CA 19-9 and CEA to predict operability and survival in pancreatic malignancies
Comparison of two immunoassays for CA19-9, CEA and AFP tumor markers - Biochemia Medica
CA 19.9 - Pancreatic Cancer Marker – Beacon Health Screening Centre
Tumor Markers in Pancreatic Cancer: 2013
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma | PLOS ONE
Common benign HPB conditions with associated deranged CA19.9 level | Download Table
Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer - Gastroenterology
The prognostic value of serum CA 19-9 for patients with advanced lung adenocarcinoma | BMC Cancer | Full Text
Cancer marker CA 19-9 (pancreatic) - Telesante
Past, Present, and Future of Serum Tumor Markers in Management of Ovarian Cancer: A Guide for the Radiologist | RadioGraphics
SciELO - Brasil - Further evidence of the prognostic role of pretreatment levels of CA 19-9 in advanced pancreatic cancer Further evidence of the prognostic role of pretreatment levels of CA 19-9
CA-19-9 - Diagnostic Kit
Clinical Value of Serum CEA, CA 19-9, CA 242 and AFP in Diagnosis of Gastrointestinal Tract Cancers
CA 19-9 Antigen - an overview | ScienceDirect Topics
